Your browser does not support the video tag.
Skip to content
home button
  • Resources
    • By Topic
      • Access to Clinical Trials
      • Artificial Intelligence
      • Clinical Trials Landscape
      • Data Collecting + Reporting
      • Ensuring Quality
      • Innovative Trials
      • Patient Engagement
      • Recruitment
      • Regulatory Submissions + Approvals
      • Safety
      • Site Planning
    • By Trial Stage
      • Study Design
        • Innovative Trials
        • Patient Group Engagement
        • Recruitment
      • Study Operations
        • Data Collecting
        • Regulatory Submissions + Approvals
        • Site Planning
  • Case Studies
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
connect with us
Signup for our Newsletter
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
Search

CTTI

Clinical Trials Transformation Initiative

Recommendations

Recommendations for Desired Attributes of Electronic Portals for Expedited Safety Reporting

Posted on June 7, 2021February 11, 2025 by Hannah Faulkner

Recommendations for Desired Attributes of Electronic Portals for Expedited Safety Reporting

Posted in Recommendations, SAE Reporting, Safety, Safety Reporting, Study Operations

Recommendations for Registry Trials

Posted on June 7, 2021February 11, 2025 by Hannah Faulkner

Recommendations for Registry Trials

Posted in Data Collecting and Reporting, Innovative Trials, Recommendations, Registry Trials, Registry Trials, Study Design

Recommendations for Planning for Successful Trial Recruitment

Posted on June 7, 2021February 10, 2025 by Hannah Faulkner

Recommendations for Planning for Successful Trial Recruitment

Posted in Ensuring Quality, Recommendations, Recruitment, Recruitment, Recruitment, Study Design, Study Operations

Recommendations for using Real-World Data to Plan Eligibility Criteria and Enhance Recruitment

Posted on June 7, 2021February 10, 2025 by Hannah Faulkner

Recommendations for using Real-World Data to Plan Eligibility Criteria and Enhance Recruitment

Posted in Real World Data, Recommendations, Recruitment, RWD for Eligibility and Recruitment, Site Planning, Study Design

Recommendations for Quality by Design

Posted on June 7, 2021February 10, 2025 by Hannah Faulkner

Recommendations for Quality by Design

Posted in Designed with Quality Approach, Ensuring Quality, Quality By Design, Quality by Design, Recommendations, Study Design

Recommendations for Effective and Efficient Monitoring as a Component of Quality Assurance in the Conduct of Clinical Trials

Posted on June 7, 2021February 10, 2025 by Hannah Faulkner

Recommendations for Effective and Efficient Monitoring as a Component of Quality Assurance in the Conduct of Clinical Trials

Posted in Designed with Quality Approach, Ensuring Quality, Quality by Design, Quality By Design, Recommendations, Study Design

Recommendations for Pregnancy Testing in Clinical Trials

Posted on June 7, 2021February 7, 2025 by Hannah Faulkner

Recommendations for Pregnancy Testing in Clinical Trials

Posted in Ensuring Quality, Planning for Pregnancy Testing, Pregnancy Testing, Recommendations, Study Design

Recommendations for Effective Engagement with Patient Groups around Clinical Trials

Posted on June 7, 2021February 7, 2025 by Hannah Faulkner

Recommendations for Effective Engagement with Patient Groups around Clinical Trials

Posted in Patient Engagement, Patient Group Engagement, Patient Group Engagement, Patient-centered, Recommendations, Study Design

Recommendations for Data Monitoring Committees

Posted on June 7, 2021January 31, 2025 by Hannah Faulkner

Recommendations for Data Monitoring Committees

Posted in Data Monitoring Committees, Data Monitoring Committees, Ensuring Quality, Recommendations, Safety, Study Operations

Recommendations for Improving Pediatric Trials in Antibacterial Drug Development

Posted on June 7, 2021November 21, 2024 by Hannah Faulkner

Recommendations for Improving Pediatric Trials in Antibacterial Drug Development

Posted in ABDD Peds Trials, Antibacterial Drug Development, Antibacterial Drug Development-Peds Trials, Novel Endpoints, Recommendations

Posts navigation

Newer posts →
 

DISCLAIMER: CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy. 

  • About
  • Newsroom
  • Membership
  • Case Studies
  • Contact Us
  • Access to Clinical Trials
  • Artificial Intelligence
  • Clinical Trials Landscape
  • Data Collecting + Reporting
  • Ensuring Quality
  • Innovative Trials
  • Informed Consent
  • Patient Group Engagement
  • Real-World Data
  • Recruitment
  • Regulatory Submissions + Approvals
  • Safety + Protection
  • Site Planning
Sign up for our Newsletter
Log in

© Clinical Trials Transformation Initiative © 2026

terms of use

privacy statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.